Pluri logo

Pluri Share Price Today

(NASDAQ: PLUR)

Pluri share price is $4.7 & ₹408.75 as on 6 Mar 2025, 2.30 'hrs' IST

$4.7

0.26

(5.86%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Pluri share price in Dollar and Rupees. Guide to invest in Pluri stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pluri, along with analyst recommendations, forecasts, and comprehensive financials.

Pluri share price movements

  • Today's Low: $4.59
    Today's High: $4.88

    Day's Volatility :5.94%

  • 52 Weeks Low: $4.07
    52 Weeks High: $8.48

    52 Weeks Volatility :52.0%

Pluri (PLUR) Returns

PeriodPluri IncIndex (Russel 2000)
3 Months
-13.75%
0.0%
6 Months
-14.29%
0.0%
1 Year
-44.5%
0.0%
3 Years
-42.79%
-11.6%

Pluri (PLUR) Key Statistics

in dollars & INR

Previous Close
$4.44
Open
$4.59
Today's High
$4.88
Today's Low
$4.59
Market Capitalization
$31.1M
Today's Volume
$2.0K
52 Week High
$8.48
52 Week Low
$4.07
Revenue TTM
$678.0K
EBITDA
$-21.5M
Earnings Per Share (EPS)
$-3.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1102.59%

How to invest in Pluri Stock (PLUR) from India?

It is very easy for Indian residents to invest directly in Pluri from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pluri stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pluri or PLUR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pluri or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pluri shares which would translate to 0.185 fractional shares of Pluri as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pluri, in just a few clicks!

Returns in Pluri (PLUR) for Indian investors in Rupees

The Pluri stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pluri investment value today

Current value as on today

₹63,713

Returns

₹36,287

(-36.29%)

Returns from Pluri Stock

₹41,250 (-41.25%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Pluri (PLUR)

29%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Pluri Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pluri

  • Renaissance Technologies Corp

    0.49%

  • Values First Advisors Inc

    0.17%

  • UBS Group AG

    0.11%

  • Morgan Stanley - Brokerage Accounts

    0.01%

Analyst Recommendation on Pluri

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pluri(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pluri Stock (PLUR)

What analysts predicted

Downside of 14.89%

Target:

$4.00

Current:

$4.70

Insights on Pluri Stock (Ticker Symbol: PLUR)

  • Price Movement

    In the last 7 days, PLUR stock has moved up by 0.3%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 326.0K → 185.0K (in $), with an average decrease of 43.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -5.88M → 1.84M (in $), with an average increase of 418.5% per quarter
  • PLUR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 99.2%
  • Price to Sales

    ForPLUR every $1 of sales, investors are willing to pay $35.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Pluri Technicals Summary

Sell

Neutral

Buy

Pluri is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pluri (PLUR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pluri Inc logo
3.26%
-14.29%
-44.5%
-42.79%
-42.79%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pluri Inc logo
NA
NA
NA
0.0
-11.03
-0.37
NA
-1.44
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pluri Inc logo
Buy
$31.1M
-42.79%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Pluri

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to COVID-19, peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, is composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and phase I trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. It also offers cell manufacturing services; cell-based coffee; and develops and commercializes cultivated meat products. The company operates in the field of regenerative medicine, food-tech, CDMO, and agtech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Organization
Pluri
Employees
106
CEO
Mr. Yaacov Yanay
Industry
Miscellaneous

Management People of Pluri

NameTitle
Mr. Yaacov Yanay
President, CEO & Director
Ms. Liat Zalts
Chief Financial Officer & Treasurer
Mr. Lior Raviv
Chief Technology Officer
Dr. Arthur Machlenkin Ph.D.
Chief Scientific Officer
Ms. Efrat Livne-Hadass
Chief Wellbeing Officer
Ms. Orly Amiran
Chief Quality Officer
Ms. Efrat Kaduri
Chief Business Development Officer of Pharma
Mr. Nimrod Bar Zvi
Chief Commercial Officer
Mr. John Dvor
Executive Vice President of North America

Important FAQs about investing in PLUR Stock from India :

What is Pluri share price today?

Pluri share price today stands at $4.70, Open: $4.59 ; Previous Close: $4.44 ; High: $4.88 ; Low: $4.59 ; 52 Week High: $8.48 ; 52 Week Low: $4.07.

The stock opens at $4.59, after a previous close of $4.44. The stock reached a daily high of $4.88 and a low of $4.59, with a 52-week high of $8.48 and a 52-week low of $4.07.

Can Indians buy Pluri shares?

Yes, Indians can invest in the Pluri (PLUR) from India.

With INDmoney, you can buy Pluri at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pluri at zero transaction cost.

How can I buy Pluri shares from India?

It is very easy to buy Pluri from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pluri (PLUR) be purchased?

Yes, you can buy fractional shares of Pluri with INDmoney app.

What are the documents required to start investing in Pluri stocks?

To start investing in Pluri, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pluri Stock (PLUR)?

Today’s highest price of Pluri (PLUR) is $4.88.

Today’s lowest price of Pluri (PLUR) is $4.59.

What is today's market capitalisation of Pluri?

Today's market capitalisation of Pluri PLUR is 31.1M

What is the 52 Week High and Low Range of Pluri Stock (PLUR)?

  • 52 Week High

    $8.48

  • 52 Week Low

    $4.07

What are the historical returns of Pluri (PLUR)?

  • 1 Month Returns

    3.26%

  • 3 Months Returns

    -14.29%

  • 1 Year Returns

    -44.5%

  • 5 Years Returns

    -42.79%

Who is the Chief Executive Officer (CEO) of Pluri ?

Mr. Yaacov Yanay is the current Chief Executive Officer (CEO) of Pluri.